Key Players in India Hydroxyzine Market | Insights & Market Overview 2026

India Hydroxyzine Market Overview

According to 6Wresearch, the hydroxyzine market in India is projected for steady growth, driven by its dual efficacy as an antihistamine and a non-habit-forming anxiolytic despite an aging population and rising mental health concerns. Under Indian pharmaceutical regulations, hydroxyzine is a prescription-only (Schedule H) medication required for managing histamine-mediated pruritus, urticaria, and acute anxiety symptoms.

With an increasing number of prescriptions managed through e-pharmacy platforms and "Direct-to-Retailer" digital supply chains, the industry is currently experiencing a rapid digital transformation.

Competitive Landscape

The competitive landscape of the India hydroxyzine market is characterized by the presence of global generics leaders, regional producers, and an expanding segment of emerging specialized firms. Leading companies hold a significant market share due to their longstanding presence in the dermatology and central nervous system (CNS) segments. To meet the growing industrial demand for safety and efficacy, they also make significant investments in research and development (R&D) to innovate low-sedation profiles and environmentally friendly manufacturing processes.

Below is a list of leading players operating in the India Hydroxyzine Market:

1. Dr. Reddy’s Laboratories Ltd.

A global leader that markets the prominent brand Atarax, widely recognized as a benchmark for efficacy in treating skin allergies and tension.

2. Mankind Pharma Ltd.

Produces and distributes Hicope, one of the most accessible and high-volume hydroxyzine brands in the Indian retail market.

3. Sun Pharmaceutical Industries Ltd.

Markets the brand Hydrox, utilizing advanced manufacturing processes to ensure high bioavailability and quality compliance.

4. Cipla Limited

Offers the brand Relax, focusing on affordable healthcare solutions for anxiety and dermatological conditions across a vast distribution network.

5. Alkem Laboratories Ltd.

Markets Anxicalm, a brand known for its precise formulation and rapid symptom relief in acute anxiety cases.

6. Zydus Lifesciences Ltd.

Produces Sedazine, frequently prescribed for its high potency and rapid onset of action in managing neuroses.

7. Lupin Limited

A major global generic player that provides high-quality hydroxyzine formulations for both domestic and international regulated markets.

8. Psychotropics India Ltd. (PIL)

A specialized manufacturer focusing on the CNS and mental health segments.

9. Neurocon Inc.

A reputed PCD pharma company offering the YESTILO brand, targeted at treating mild to moderate allergic symptoms.

10. Bioxtreme Pharma Pvt. Ltd.

Produces DROXTIL-10, a leading brand in the specialized dermatology and pruritus segment.

11. Healing Pharma India Pvt. Ltd.

Offers the ATARISE brand, focusing on high-volume availability and affordable pricing for long-term management of chronic allergic skin conditions.

12. Nexwin Pharma

Markets PROXYZIN-25, a brand recognized for its cost-effectiveness and accessibility through a robust PCD (Propaganda Cum Distribution) franchise model.